Pfizer Initiates Second Legal Action Against Novo Nordisk and Metsera Over Obesity Biotech Acquisition

Pfizer has launched a second lawsuit targeting Novo Nordisk and the obesity biotech startup Metsera, claiming that Novo Nordisk's efforts to acquire Metsera are anticompetitive practices.